Cargando…
13,14-bis(cis-3,5-dimethyl-1-piperazinyl)-β-elemene, a novel β-elemene derivative, shows potent antitumor activities via inhibition of mTOR in human breast cancer cells
Elemene has been approved for the treatment of advanced cancer in China, however, it inhibits cell growth only at high concentrations and is an essential oil with poor water solubility and stability. The discovery of new β-elemene derivatives is of increasing interest. We recently reported that the...
Autores principales: | DING, XIAO-FEI, SHEN, MAO, XU, LI-YING, DONG, JIN-HUA, CHEN, GUANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678516/ https://www.ncbi.nlm.nih.gov/pubmed/23761818 http://dx.doi.org/10.3892/ol.2013.1213 |
Ejemplares similares
-
Antitumor effects of β-elemene via targeting the phosphorylation of insulin receptor
por: Wu, Dawei, et al.
Publicado: (2018) -
Combinatorial Antitumor Effect of Rapamycin and β-Elemene in Follicular Thyroid Cancer Cells
por: Zhou, Jun, et al.
Publicado: (2016) -
The Antitumor Efficacy of β-Elemene by Changing Tumor Inflammatory Environment and Tumor Microenvironment
por: Xie, Qiang, et al.
Publicado: (2020) -
Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
por: Zhai, Bingtao, et al.
Publicado: (2018) -
β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)